HEADER TRANSFERASE/TRANSFERASE INHIBITOR 07-JAN-17 5UGA TITLE CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN (L858R, T790M, V948R) IN TITLE 2 COMPLEX WITH 4-(4-{[2-{[(3S)-1-ACETYLPYRROLIDIN-3-YL]AMINO}-9- TITLE 3 (PROPAN-2-YL)-9H-PURIN-6-YL]AMINO}PHENYL)-1-METHYLPIPERAZIN-1-IUM COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPIDERMAL GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 695-1022; COMPND 5 SYNONYM: PROTO-ONCOGENE C-ERBB-1,RECEPTOR TYROSINE-PROTEIN KINASE COMPND 6 ERBB-1; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EGFR, ERBB, ERBB1, HER1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA AFF. FRUGIPERDA 2 RZ-2014; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 1491790 KEYWDS KINASE, COVALENT INHIBITOR, LUNG CANCER, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.S.GAJIWALA,R.A.FERRE REVDAT 3 06-MAR-24 5UGA 1 REMARK REVDAT 2 26-APR-17 5UGA 1 JRNL REVDAT 1 22-MAR-17 5UGA 0 JRNL AUTH S.PLANKEN,D.C.BEHENNA,S.K.NAIR,T.O.JOHNSON,A.NAGATA, JRNL AUTH 2 C.ALMADEN,S.BAILEY,T.E.BALLARD,L.BERNIER,H.CHENG, JRNL AUTH 3 S.CHO-SCHULTZ,D.DALVIE,J.G.DEAL,D.M.DINH,M.P.EDWARDS, JRNL AUTH 4 R.A.FERRE,K.S.GAJIWALA,M.HEMKENS,R.S.KANIA,J.C.KATH, JRNL AUTH 5 J.MATTHEWS,B.W.MURRAY,S.NIESSEN,S.T.ORR,M.PAIRISH,N.W.SACH, JRNL AUTH 6 H.SHEN,M.SHI,J.SOLOWIEJ,K.TRAN,E.TSENG,P.VICINI,Y.WANG, JRNL AUTH 7 S.L.WEINRICH,R.ZHOU,M.ZIENTEK,L.LIU,Y.LUO,S.XIN,C.ZHANG, JRNL AUTH 8 J.LAFONTAINE JRNL TITL DISCOVERY OF JRNL TITL 2 N-((3R,4R)-4-FLUORO-1-(6-((3-METHOXY-1-METHYL-1H-PYRAZOL-4-Y JRNL TITL 3 L)AMINO)-9-METHYL-9H-PURIN-2-YL)PYRROLIDINE-3-YL)ACRYLAMIDE JRNL TITL 4 (PF-06747775) THROUGH STRUCTURE-BASED DRUG DESIGN: A HIGH JRNL TITL 5 AFFINITY IRREVERSIBLE INHIBITOR TARGETING ONCOGENIC EGFR JRNL TITL 6 MUTANTS WITH SELECTIVITY OVER WILD-TYPE EGFR. JRNL REF J. MED. CHEM. V. 60 3002 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28287730 JRNL DOI 10.1021/ACS.JMEDCHEM.6B01894 REMARK 2 REMARK 2 RESOLUTION. 1.82 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 58.85 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1412291.730 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 28809 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.235 REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1431 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2350 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2330 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1437 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0070 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.82 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.93 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4357 REMARK 3 BIN R VALUE (WORKING SET) : 0.4480 REMARK 3 BIN FREE R VALUE : 0.4610 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 231 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2276 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 63 REMARK 3 SOLVENT ATOMS : 160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 22.75000 REMARK 3 B22 (A**2) : -12.29000 REMARK 3 B33 (A**2) : -10.46000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.54 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.50 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 0.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.630 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.290 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.990 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.190 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.170 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 42.77 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UGA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1000225823. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-APR-13 REMARK 200 TEMPERATURE (KELVIN) : 98 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28868 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.820 REMARK 200 RESOLUTION RANGE LOW (A) : 58.850 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09900 REMARK 200 FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : 0.46200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SALT: 0.2 M AMMONIUM SULFATE REMARK 280 PRECIPITANT: 20.0 %W/V PEG 8000 BUFFER: 0.1 M HEPES (PH 7.50) REMARK 280 PRECIPITANT: 13.6 %V/V ISO-PROPANOL, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.45200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.10900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.79750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.10900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.45200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.79750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 694 REMARK 465 SER A 695 REMARK 465 GLY A 696 REMARK 465 GLU A 697 REMARK 465 ALA A 698 REMARK 465 PRO A 699 REMARK 465 ASN A 700 REMARK 465 GLN A 701 REMARK 465 ALA A 702 REMARK 465 ARG A 986 REMARK 465 MET A 987 REMARK 465 HIS A 988 REMARK 465 LEU A 989 REMARK 465 PRO A 990 REMARK 465 SER A 991 REMARK 465 PRO A 992 REMARK 465 THR A 993 REMARK 465 ASP A 994 REMARK 465 SER A 995 REMARK 465 ASN A 996 REMARK 465 PHE A 997 REMARK 465 TYR A 998 REMARK 465 ARG A 999 REMARK 465 ALA A 1000 REMARK 465 LEU A 1001 REMARK 465 MET A 1002 REMARK 465 ASP A 1003 REMARK 465 GLU A 1004 REMARK 465 GLU A 1005 REMARK 465 ASP A 1006 REMARK 465 MET A 1007 REMARK 465 ASP A 1008 REMARK 465 ASP A 1009 REMARK 465 VAL A 1010 REMARK 465 VAL A 1011 REMARK 465 ASP A 1012 REMARK 465 ALA A 1013 REMARK 465 ASP A 1014 REMARK 465 GLU A 1015 REMARK 465 TYR A 1016 REMARK 465 LEU A 1017 REMARK 465 ILE A 1018 REMARK 465 PRO A 1019 REMARK 465 GLN A 1020 REMARK 465 GLN A 1021 REMARK 465 GLY A 1022 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 783 -118.78 -122.18 REMARK 500 ASP A 837 34.19 -149.78 REMARK 500 GLU A 872 -154.87 -105.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8BM A 9001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 9002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 9003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 9004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 9005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 9006 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5UG8 RELATED DB: PDB REMARK 900 RELATED ID: 5UG9 RELATED DB: PDB REMARK 900 RELATED ID: 5UGB RELATED DB: PDB REMARK 900 RELATED ID: 5UGC RELATED DB: PDB DBREF 5UGA A 695 1022 UNP P00533 EGFR_HUMAN 695 1022 SEQADV 5UGA GLY A 694 UNP P00533 EXPRESSION TAG SEQADV 5UGA MET A 790 UNP P00533 THR 790 ENGINEERED MUTATION SEQADV 5UGA ARG A 858 UNP P00533 LEU 858 ENGINEERED MUTATION SEQADV 5UGA ARG A 948 UNP P00533 VAL 948 ENGINEERED MUTATION SEQRES 1 A 329 GLY SER GLY GLU ALA PRO ASN GLN ALA LEU LEU ARG ILE SEQRES 2 A 329 LEU LYS GLU THR GLU PHE LYS LYS ILE LYS VAL LEU GLY SEQRES 3 A 329 SER GLY ALA PHE GLY THR VAL TYR LYS GLY LEU TRP ILE SEQRES 4 A 329 PRO GLU GLY GLU LYS VAL LYS ILE PRO VAL ALA ILE LYS SEQRES 5 A 329 GLU LEU ARG GLU ALA THR SER PRO LYS ALA ASN LYS GLU SEQRES 6 A 329 ILE LEU ASP GLU ALA TYR VAL MET ALA SER VAL ASP ASN SEQRES 7 A 329 PRO HIS VAL CYS ARG LEU LEU GLY ILE CYS LEU THR SER SEQRES 8 A 329 THR VAL GLN LEU ILE MET GLN LEU MET PRO PHE GLY CYS SEQRES 9 A 329 LEU LEU ASP TYR VAL ARG GLU HIS LYS ASP ASN ILE GLY SEQRES 10 A 329 SER GLN TYR LEU LEU ASN TRP CYS VAL GLN ILE ALA LYS SEQRES 11 A 329 GLY MET ASN TYR LEU GLU ASP ARG ARG LEU VAL HIS ARG SEQRES 12 A 329 ASP LEU ALA ALA ARG ASN VAL LEU VAL LYS THR PRO GLN SEQRES 13 A 329 HIS VAL LYS ILE THR ASP PHE GLY ARG ALA LYS LEU LEU SEQRES 14 A 329 GLY ALA GLU GLU LYS GLU TYR HIS ALA GLU GLY GLY LYS SEQRES 15 A 329 VAL PRO ILE LYS TRP MET ALA LEU GLU SER ILE LEU HIS SEQRES 16 A 329 ARG ILE TYR THR HIS GLN SER ASP VAL TRP SER TYR GLY SEQRES 17 A 329 VAL THR VAL TRP GLU LEU MET THR PHE GLY SER LYS PRO SEQRES 18 A 329 TYR ASP GLY ILE PRO ALA SER GLU ILE SER SER ILE LEU SEQRES 19 A 329 GLU LYS GLY GLU ARG LEU PRO GLN PRO PRO ILE CYS THR SEQRES 20 A 329 ILE ASP VAL TYR MET ILE MET ARG LYS CYS TRP MET ILE SEQRES 21 A 329 ASP ALA ASP SER ARG PRO LYS PHE ARG GLU LEU ILE ILE SEQRES 22 A 329 GLU PHE SER LYS MET ALA ARG ASP PRO GLN ARG TYR LEU SEQRES 23 A 329 VAL ILE GLN GLY ASP GLU ARG MET HIS LEU PRO SER PRO SEQRES 24 A 329 THR ASP SER ASN PHE TYR ARG ALA LEU MET ASP GLU GLU SEQRES 25 A 329 ASP MET ASP ASP VAL VAL ASP ALA ASP GLU TYR LEU ILE SEQRES 26 A 329 PRO GLN GLN GLY HET 8BM A9001 35 HET SO4 A9002 5 HET SO4 A9003 5 HET GOL A9004 6 HET GOL A9005 6 HET GOL A9006 6 HETNAM 8BM 4-(4-{[2-{[(3S)-1-ACETYLPYRROLIDIN-3-YL]AMINO}-9- HETNAM 2 8BM (PROPAN-2-YL)-9H-PURIN-6-YL]AMINO}PHENYL)-1- HETNAM 3 8BM METHYLPIPERAZIN-1-IUM HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN 8BM 1-[(3S)-3-{[6-{[4-(4-METHYLPIPERAZIN-1-YL) HETSYN 2 8BM PHENYL]AMINO}-9-(PROPAN-2-YL)-9H-PURIN-2- HETSYN 3 8BM YL]AMINO}PYRROLIDIN-1-YL]ETHAN-1-ONE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 8BM C25 H35 N9 O FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 GOL 3(C3 H8 O3) FORMUL 8 HOH *160(H2 O) HELIX 1 AA1 ALA A 755 SER A 768 1 14 HELIX 2 AA2 CYS A 797 HIS A 805 1 9 HELIX 3 AA3 LYS A 806 ILE A 809 5 4 HELIX 4 AA4 GLY A 810 ARG A 831 1 22 HELIX 5 AA5 ALA A 839 ARG A 841 5 3 HELIX 6 AA6 PRO A 877 MET A 881 5 5 HELIX 7 AA7 ALA A 882 ARG A 889 1 8 HELIX 8 AA8 THR A 892 THR A 909 1 18 HELIX 9 AA9 PRO A 919 SER A 921 5 3 HELIX 10 AB1 GLU A 922 LYS A 929 1 8 HELIX 11 AB2 THR A 940 CYS A 950 1 11 HELIX 12 AB3 ASP A 954 ARG A 958 5 5 HELIX 13 AB4 LYS A 960 ARG A 973 1 14 HELIX 14 AB5 ASP A 974 LEU A 979 1 6 SHEET 1 AA1 6 ARG A 705 ILE A 706 0 SHEET 2 AA1 6 LEU A 777 LEU A 782 1 O ILE A 780 N ARG A 705 SHEET 3 AA1 6 VAL A 786 GLN A 791 -1 O ILE A 789 N GLY A 779 SHEET 4 AA1 6 ILE A 740 LEU A 747 -1 N ALA A 743 O MET A 790 SHEET 5 AA1 6 GLY A 724 TRP A 731 -1 N TRP A 731 O ILE A 740 SHEET 6 AA1 6 PHE A 712 GLY A 721 -1 N LEU A 718 O VAL A 726 SHEET 1 AA2 2 LEU A 833 VAL A 834 0 SHEET 2 AA2 2 LYS A 860 LEU A 861 -1 O LYS A 860 N VAL A 834 SHEET 1 AA3 2 VAL A 843 THR A 847 0 SHEET 2 AA3 2 HIS A 850 ILE A 853 -1 O LYS A 852 N LEU A 844 SHEET 1 AA4 2 TYR A 869 HIS A 870 0 SHEET 2 AA4 2 ILE A 890 TYR A 891 -1 O TYR A 891 N TYR A 869 SITE 1 AC1 12 LEU A 718 GLY A 719 SER A 720 VAL A 726 SITE 2 AC1 12 ALA A 743 GLN A 791 MET A 793 PRO A 794 SITE 3 AC1 12 GLY A 796 ASN A 842 LEU A 844 THR A 854 SITE 1 AC2 7 ARG A 836 TYR A 869 ALA A 871 GLU A 872 SITE 2 AC2 7 GLY A 873 HOH A9113 HOH A9182 SITE 1 AC3 3 ARG A 803 LYS A 913 HOH A9131 SITE 1 AC4 5 SER A 752 ASN A 816 GLN A 820 LYS A 823 SITE 2 AC4 5 HOH A9102 SITE 1 AC5 8 THR A 940 ILE A 941 ASP A 942 ARG A 977 SITE 2 AC5 8 TYR A 978 HOH A9121 HOH A9162 HOH A9188 SITE 1 AC6 4 LEU A 747 ALA A 750 PRO A 753 LYS A 754 CRYST1 40.904 69.595 110.218 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024447 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014369 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009073 0.00000